 | • レポートコード：MRC2207A069 • 出版社/出版日：Transparency Market Research / 2022年5月 • レポート形態：英文、PDF、230ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| トランスペアレンシー・マーケット・リサーチ社の本調査レポートでは、世界の粒子線治療市場について総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、治療別（陽子線治療、重イオン治療）分析、用途別分析、サービス別分析、最終用途別分析、地域別（北米、ヨーロッパ、アジア太平洋、その他地域）分析、競争状況などの内容をまとめております。なお、本書に掲載されている企業情報にはVarian Medical Systems, Inc.、Sumitomo Heavy Industries, Ltd.、Provision Healthcare、Protom International, Inc.、Optivus Proton Therapy, Inc.、Mevion Medical Systems, Inc.、IBA Worldwide、Hitachi, Ltd.、Danfysik A/S、Advanced Oncotherapy plcなどが含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の粒子線治療市場規模：治療別（陽子線治療、重イオン治療） ・世界の粒子線治療市場規模：用途別 ・世界の粒子線治療市場規模：サービス別 ・世界の粒子線治療市場規模：最終用途別 ・世界の粒子線治療市場規模：地域別（北米、ヨーロッパ、アジア太平洋、その他地域） ・競争状況 |
Particle Therapy Market – Scope of Report
TMR’s report on the global particle therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global particle therapy market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global particle therapy market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the particle therapy market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global particle therapy market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global particle therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global particle therapy market.
The report delves into the competitive landscape of the global particle therapy market. Key players operating in the global particle therapy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global particle therapy market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market particle therapy.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Particle Therapy Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Particle Therapy Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Reimbursement Scenario
5.3. Particle Therapy Facilities In Clinical Operation, 2021
5.4. Average Prices, by Region, 2021
5.5. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Particle Therapy Market Analysis and Forecast, By Therapy
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Therapy, 2017–2031
6.3.1. Proton Therapy
6.3.2. Heavy Ion Therapy (carbon therapy, He, pion)
6.4. Market Attractiveness Analysis, By Therapy
7. Global Particle Therapy Market Analysis and Forecast, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Pediatric Cancer
7.3.2. Lung Cancer
7.3.3. Bladder Cancer
7.3.4. Brain & Spinal Cord Tumors (BSCT)
7.3.5. Breast Cancer
7.3.6. Gastrointestinal (GI) Cancers
7.3.7. Hepatocellular Carcinoma (HCC)
7.3.8. Head & Neck Cancers (HNC)
7.3.9. Others
7.4. Market Attractiveness Analysis, By Application
8. Global Particle Therapy Market Analysis and Forecast, By Service
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Service, 2017–2031
8.3.1. Cyclotrons
8.3.2. Synchrotrons
8.3.3. Synchrocyclotrons
8.4. Market Attractiveness Analysis, By Service
9. Global Particle Therapy Market Analysis and Forecast, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Academic & Research Centers
9.4. Market Attractiveness Analysis, By End-user
10. Global Particle Therapy Market Analysis and Forecast, By Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Rest of the World
10.3. Market Attractiveness Analysis, By Region
11. North America Particle Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Therapy, 2017–2031
11.2.1. Proton Therapy
11.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Pediatric Cancer
11.3.2. Lung Cancer
11.3.3. Bladder Cancer
11.3.4. Brain & Spinal Cord Tumors (BSCT)
11.3.5. Breast Cancer
11.3.6. Gastrointestinal (GI) Cancers
11.3.7. Hepatocellular Carcinoma (HCC)
11.3.8. Head & Neck Cancers (HNC)
11.3.9. Others
11.4. Market Value Forecast, by Service, 2017–2031
11.4.1. Cyclotrons
11.4.2. Synchrotrons
11.4.3. Synchrocyclotrons
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Academic & Research Centers
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Therapy
11.7.2. By Application
11.7.3. By Service
11.7.4. By End-user
11.7.5. By Country
12. Europe Particle Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Therapy, 2017–2031
12.2.1. Proton Therapy
12.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Pediatric Cancer
12.3.2. Lung Cancer
12.3.3. Bladder Cancer
12.3.4. Brain & Spinal Cord Tumors (BSCT)
12.3.5. Breast Cancer
12.3.6. Gastrointestinal (GI) Cancers
12.3.7. Hepatocellular Carcinoma (HCC)
12.3.8. Head & Neck Cancers (HNC)
12.3.9. Others
12.4. Market Value Forecast, by Service, 2017–2031
12.4.1. Cyclotrons
12.4.2. Synchrotrons
12.4.3. Synchrocyclotrons
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Academic & Research Centers
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Therapy
12.7.2. By Application
12.7.3. By Service
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Particle Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Therapy, 2017–2031
13.2.1. Proton Therapy
13.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Pediatric Cancer
13.3.2. Lung Cancer
13.3.3. Bladder Cancer
13.3.4. Brain & Spinal Cord Tumors (BSCT)
13.3.5. Breast Cancer
13.3.6. Gastrointestinal (GI) Cancers
13.3.7. Hepatocellular Carcinoma (HCC)
13.3.8. Head & Neck Cancers (HNC)
13.3.9. Others
13.4. Market Value Forecast, by Service, 2017–2031
13.4.1. Cyclotrons
13.4.2. Synchrotrons
13.4.3. Synchrocyclotrons
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Academic & Research Centers
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Therapy
13.7.2. By Application
13.7.3. By Service
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Rest of the World Particle Therapy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Therapy, 2017–2031
14.2.1. Proton Therapy
14.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Pediatric Cancer
14.3.2. Lung Cancer
14.3.3. Bladder Cancer
14.3.4. Brain & Spinal Cord Tumors (BSCT)
14.3.5. Breast Cancer
14.3.6. Gastrointestinal (GI) Cancers
14.3.7. Hepatocellular Carcinoma (HCC)
14.3.8. Head & Neck Cancers (HNC)
14.3.9. Others
14.4. Market Value Forecast, by Service, 2017–2031
14.4.1. Cyclotrons
14.4.2. Synchrotrons
14.4.3. Synchrocyclotrons
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Academic & Research Centers
14.6. Market Attractiveness Analysis
14.6.1. By Therapy
14.6.2. By Application
14.6.3. By Service
14.6.4. By End-user
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Advanced Oncotherapy plc
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Danfysik A/S
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Hitachi, Ltd.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. IBA Worldwide
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Mevion Medical Systems, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Optivus Proton Therapy, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Protom International, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Provision Healthcare
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Sumitomo Heavy Industries, Ltd.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. Varian Medical Systems, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
Table 01: Global Particle Therapy Market Value (US$ Mn) Forecast, by Therapy 2017–2031
Table 02: Global Particle Therapy Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 03: Global Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017‒2031
Table 04: Global Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 05: Global Particle Therapy Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Particle Therapy Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 08: North America Particle Therapy Market (US$ Mn) Forecast, by Application, 2017–2031
Table 09: North America Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 10: North America Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 13: Europe Particle Therapy Market (US$ Mn) Forecast, by Application, 2017–2031
Table 14: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 15: Europe Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 18: Asia Pacific Particle Therapy Market (US$ Mn) Forecast, by Application, 2017–2031
Table 19: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 20: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 22: Rest of the World Particle Therapy Market (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 24: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031